BrightMeds vs PlexusDx: GLP-1 Plans and Prices Compared (2026)

Last reviewed: September 8, 2026 Last updated: September 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

BrightMeds' 3-month prepaid plans cost substantially less than PlexusDx across both semaglutide and tirzepatide: $99/month prepaid ($297 upfront) for semaglutide versus PlexusDx's $169/month 3-month prepaid rate, and $119/month prepaid ($357 upfront) for tirzepatide versus PlexusDx's $269/month. BrightMeds' month-to-month rates are also lower—$129 semaglutide versus PlexusDx's $189, and $149 tirzepatide versus PlexusDx's $289. The trade-off: BrightMeds' pricing is labeled a "summer special," is state-limited, and offers only injectable semaglutide and tirzepatide, while PlexusDx provides oral formulations, microdose maintenance options, and a 6-month prepaid tier BrightMeds does not offer. BrightMeds holds a 4.8-star Trustpilot rating with 900+ reviews (captured September 4, 2026); PlexusDx holds a 4.3-star rating, with 79% of reviews at five stars and 83% at four stars or higher. If you want the lowest per-month cost and live in a participating state, BrightMeds' promotional pricing delivers meaningful savings. If you value medication variety, established non-promotional terms, or longer prepaid commitment discounts, PlexusDx may be the better fit.

At-a-glance comparison

Month-to-month and prepaid pricing compared

Both providers eliminate membership fees and bundle medication, provider evaluation, follow-up, and shipping into a single monthly or prepaid charge. The difference lies in the per-month cost and the prepayment terms.

Semaglutide injection pricing

BrightMeds charges $129/month on a month-to-month basis. Its 3-month prepaid plan costs $297 upfront, which works out to $99/month prepaid (our calculation). PlexusDx charges $189/month month-to-month, $169/month on a 3-month prepaid commitment ($507 upfront), and $149/month on a 6-month prepaid commitment ($894 upfront).

Over 12 months, BrightMeds' month-to-month plan totals $1,548 versus PlexusDx's $2,268—a $720 difference favoring BrightMeds. BrightMeds' 3-month prepaid plan, renewed four times, totals $1,188 versus PlexusDx's 3-month rate at $2,028—an $840 savings. PlexusDx's 6-month prepaid plan, renewed twice, totals $1,788, still $600 more than BrightMeds' 3-month option but $480 less than PlexusDx's own month-to-month rate (all 12-month totals are our calculation).

Tirzepatide injection pricing

BrightMeds charges $149/month month-to-month and $357 upfront for 3 months, which works out to $119/month prepaid (our calculation). PlexusDx charges $289/month month-to-month, $269/month for 3 months prepaid ($807 upfront), and $249/month for 6 months prepaid ($1,494 upfront).

Over 12 months, BrightMeds' month-to-month plan costs $1,788 versus PlexusDx's $3,468—a $1,680 gap. BrightMeds' 3-month prepaid option totals $1,428 over a year versus PlexusDx's $3,228—an $1,800 difference. PlexusDx's 6-month prepaid plan totals $2,988, still $1,560 more than BrightMeds' 3-month rate but $480 less than PlexusDx's own month-to-month (all calculations ours).

Both providers charge the same price at every dose, so the figures above hold whether you start at a low dose or reach maintenance.

What the promotional label means

BrightMeds describes its current pricing as a "summer special" and notes it is state-limited (captured September 4, 2026, from brightmeds.com/summer-special). The sources do not document which states qualify, how long the promotion will run, or what standard rates will apply after the promotion ends. Promotional pricing can deliver real savings, but it introduces uncertainty: if you start on a summer rate and the program reverts to higher standard pricing mid-treatment, your monthly cost may rise. The evidence does not show whether BrightMeds guarantees current enrollees will keep their introductory rate beyond the promotional window—confirm continuation terms at checkout if that matters to your decision.

PlexusDx publishes standard, non-promotional rates with no seasonal windows or state restrictions. The month-to-month and prepaid rates shown above are standing prices, not limited-time offers.

Medication options and formulation differences

BrightMeds offers compounded semaglutide injection and compounded tirzepatide injection. It does not offer oral formulations or microdose maintenance protocols (verified September 4, 2026). PlexusDx offers compounded semaglutide and tirzepatide in both injectable and oral-capsule forms, plus a microdose GLP-1 injection protocol priced at $129/month month-to-month. If you prefer or require an oral route, cannot tolerate injections, or want a low-dose maintenance option after reaching goal weight, PlexusDx provides those pathways; BrightMeds does not.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Service quality and review records

BrightMeds holds a 4.8-star rating on Trustpilot with over 900 reviews (captured September 4, 2026). PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 4, 2026). BrightMeds' higher rating and larger review volume suggest strong customer satisfaction. The review-evidence pass conducted September 4, 2026, found no dominant negative theme in indexed Trustpilot or Reddit results for BrightMeds; however, absence of captured complaints in a snapshot review is not the same as absence of complaints—only that no recurring pattern emerged in the sources indexed that day.

Higher ratings do not guarantee your individual experience, and a 4.3-star record does not indicate poor service—PlexusDx's distribution shows most customers rate the program positively. Both providers include follow-up support and dose adjustments in their plans, so ongoing clinical oversight is built into the published prices.

Strengths and gaps

BrightMeds strengths

• Substantially lower pricing: $720–$1,680 less per year than PlexusDx, depending on medication and plan structure (our 12-month calculation).
• Higher review rating: 4.8 stars with 900+ Trustpilot reviews, versus PlexusDx's 4.3.
• No membership fees: medication, provider visit, follow-up, and shipping bundled into one transparent price.
• Month-to-month flexibility: $129 semaglutide or $149 tirzepatide with no upfront commitment.

BrightMeds gaps

• Promotional and state-limited: pricing labeled a "summer special"; durability and post-promotion rates unknown.
• No oral or microdose options: injectables only, no alternative routes or maintenance protocols.
• No 6-month prepaid tier: maximum commitment is 3 months; longer-term discount unavailable.
• Limited geographic reach: state restrictions apply, but qualifying states not documented in public sources.

PlexusDx strengths

• Broader medication menu: injectable and oral semaglutide, injectable and oral tirzepatide, plus microdose GLP-1 for maintenance.
• 6-month prepaid option: deeper discount for longer commitment ($149/month semaglutide, $249/month tirzepatide, prepaid).
• Standard, non-promotional pricing: no seasonal windows, no state restrictions, published rates stable across signup dates.
• Documented review record: 4.3 stars with 83% of reviews four stars or higher; most customers report positive outcomes.

PlexusDx gaps

• Higher per-month cost: $60–$140 more per month than BrightMeds depending on medication and plan term.
• Lower Trustpilot rating: 4.3 versus BrightMeds' 4.8, though both reflect majority-positive feedback.

Choose BrightMeds if…

• You live in a state where the summer promotion is available and want the lowest possible monthly cost for compounded semaglutide or tirzepatide injection.
• You are comfortable starting on promotional pricing and can adapt if rates change after the promotion ends.
• You prefer injections and do not need oral or microdose alternatives.
• A 4.8-star review rating and 900+ customer testimonials give you confidence in service quality and support responsiveness.
• You value month-to-month flexibility at $129 semaglutide or $149 tirzepatide with no upfront payment.

Choose PlexusDx if…

• You want stable, non-promotional pricing with no seasonal windows or state restrictions—rates you can rely on today and six months from now.
• You prefer or require an oral formulation, cannot tolerate injections, or want a microdose maintenance protocol after reaching goal weight.
• You are willing to commit to six months upfront in exchange for a lower per-month rate ($149 semaglutide, $249 tirzepatide prepaid).
• You value medication variety and the ability to switch routes or compounds without changing providers.
• A 4.3-star rating with 83% four-star-or-higher reviews and a transparent, evidence-documented track record meet your service-confidence threshold.

The bottom line

BrightMeds wins decisively on price, charging $720–$1,680 less per year than PlexusDx for comparable injectable GLP-1 medications. Its 4.8-star rating and 900+ reviews suggest most customers are satisfied with the service. The trade-off is promotional pricing that may not last, state limitations that may exclude you, and a medication menu limited to two injectable compounds. PlexusDx costs more but offers oral and microdose options BrightMeds does not, a 6-month prepaid tier for deeper long-term discounts, and standard pricing with no promotional windows. If your priority is the lowest monthly cost and you live in a qualifying state, BrightMeds delivers clear savings. If you value medication flexibility, stable terms, or longer prepaid commitments, PlexusDx may justify the higher per-month rate.

Methodology and freshness

BrightMeds pricing and plan terms were captured September 4, 2026, at 13:49:55 UTC from the provider's summer-special landing page (brightmeds.com/summer-special). PlexusDx pricing reflects the standing rate structure as of September 8, 2026, and was cross-checked against the July 17–23, 2026, evidence pass. Trustpilot ratings and review volumes for both providers were captured September 4, 2026. All 12-month cost totals and prepaid per-month calculations are ours, derived from the verified plan prices by multiplying the applicable rate by the number of billing cycles in one year. "Prepaid" labels indicate upfront payment required; "month-to-month" indicates no prepayment. No price was derived by applying promotional arithmetic—every figure published here was observed directly on the provider's site or calculated transparently from documented plan terms. Confirm all pricing, state availability, and promotional continuation terms at checkout, as offers and restrictions may change after publication.

Frequently Asked Questions

Does BrightMeds' promotional pricing apply in all states?

No. BrightMeds labels its current pricing a "summer special" and notes it is state-limited. The public sources captured September 4, 2026, do not list which states qualify. Confirm your state's eligibility and whether promotional rates continue beyond the initial term before committing to a prepaid plan.

Can I switch from BrightMeds to PlexusDx mid-treatment?

Switching compounded GLP-1 providers mid-treatment is possible if a licensed clinician at the new provider reviews your history and determines a prescription is appropriate, but neither provider guarantees dose matching, formulation matching, or uninterrupted supply during the transition. Expect a new intake, possible re-titration, and potential gaps in dosing.

Why does PlexusDx cost more if both providers offer compounded semaglutide and tirzepatide?

Pricing differences reflect each provider's cost structure, pharmacy partnerships, service model, and margin decisions. PlexusDx offers oral formulations and microdose maintenance protocols BrightMeds does not, which may influence overall pricing. BrightMeds' promotional rates may also reflect a limited-time customer-acquisition strategy rather than a sustainable long-term price point.

Are the medications clinically similar between BrightMeds and PlexusDx?

Both providers dispense compounded semaglutide and tirzepatide from licensed 503A compounding pharmacies, but compounded medications are not FDA-approved and may vary in formulation, excipients, concentration, and manufacturing process. Neither provider's compounded product is interchangeable with FDA-approved branded drugs like Ozempic, Wegovy, Mounjaro, or Zepbound.

Will my insurance cover either program?

Most insurance plans do not cover compounded GLP-1 medications purchased through telehealth providers. Both BrightMeds and PlexusDx operate as direct-pay services; you pay the published monthly or prepaid rate out of pocket. Check your plan's pharmacy benefits and prior-authorization requirements if you want to explore insurance-covered branded options instead.

Sources

• PlexusDx pricing and product details, verified July 17–23, 2026, and September 8, 2026, from plexusdx.com product pages and collections.
• BrightMeds pricing, plan terms, medication offerings, and promotional details captured September 4, 2026, at 13:49:55 UTC from brightmeds.com/summer-special.
• Trustpilot ratings and review volumes for BrightMeds and PlexusDx captured September 4, 2026.
• Compounded-medication regulatory status and 503A pharmacy disclosure language from FDA guidance and PlexusDx compliance documentation.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.